Challenges and opportunities for the implementation of virological testing in resource‐limited settings
Authors:
Open Access
- 1 April 2012
- journal article
- research article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 15 (2) , 17324
Abstract
Though the advantages of routine virological monitoring for patients on anti‐retroviral therapy have been established, cost and complexity limit its full implementation. Monitoring is important for diagnosing virological failure early on, before the development of drug resistance mutations, and to trigger early adherence interventions. Simple and cost‐effective viral load tests that facilitate simplification and decentralization of testing and strategies, such as the use of dried blood spots and pooled sample testing, which further aid simplification, are becoming available. In addition, replacing immunological monitoring with virological monitoring in non‐viremic patients in a phased manner will reduce the costs associated with dual immuno‐virological monitoring. Going forward, the simplification of testing paired with price reducing strategies that will allow for healthy competition between multiple manufacturers will enable the implementation of viral load testing in resource‐poor settings. It is important that future HIV and AIDS treatment guidelines provide clear recommendations for routine virological monitoring and that governments and donors fund the implementation of accurate and operationally proven testing platforms in a comprehensive manner.Keywords
This publication has 57 references indexed in Scilit:
- Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited SettingsClinical Infectious Diseases, 2011
- Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trialThe Lancet Infectious Diseases, 2011
- HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational studyThe Lancet Infectious Diseases, 2011
- Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern AfricaAIDS, 2011
- Viremia Copy-Years Predicts Mortality Among Treatment-Naive HIV-Infected Patients Initiating Antiretroviral TherapyClinical Infectious Diseases, 2011
- Pooling Strategies to Reduce the Cost of HIV-1 RNA Load Monitoring in a Resource-Limited SettingClinical Infectious Diseases, 2010
- Viral Load Predicts New World Health Organization Stage 3 and 4 Events in HIV‐Infected Children Receiving Highly Active Antiretroviral Therapy, Independent of CD4 T Lymphocyte ValueClinical Infectious Diseases, 2010
- Advances in developing HIV-1 viral load assays for resource-limited settingsBiotechnology Advances, 2010
- Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settingsCochrane Database of Systematic Reviews, 2010
- Comparison of CD4 Cell Count, Viral Load, and Other Markers for the Prediction of Mortality among HIV‐1–Infected Kenyan Pregnant WomenThe Journal of Infectious Diseases, 2009